Check out CRN's latest press releases in our feed, or search for your topics of interest. Members of the media, learn more here about working with CRN for science-based information for your reporting.
JULY 27, 2026 — The recent Washington Post investigation and the New York Times opinion essay both raise legitimate concerns about the rapid growth of unapproved injectable peptide products and efforts to sidestep drug review of these products. CRN shares these concerns. Consumers deserve products that are backed by sound science and companies that comply with the law.
Read more
Read more
